Laboratoires Negma Overview
- Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
187
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Laboratoires Negma General Information
Description
Manufacturer of pharmaceutical products. The company manufactures and distributes products such as osteoarthritis, anti-hemorrhoids, anti-hypertension, rheumatology, phlebotonic and vesical instability.
Contact Information
Formerly Known As
Negma Lerads
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 10 rue Paul Dautier
- 78141 Vélizy-Villacoublay
- France
Laboratoires Negma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Laboratoires Negma Patents
Laboratoires Negma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2002231927-A1 | Use of rhein for preparing a medicine for treating a high level of il-1 | Abandoned | 23-Jan-2001 | 000000000 | |
| CA-2434052-A1 | Use of rhein for preparing a medicine for treating a high level of il-1 | Abandoned | 23-Jan-2001 | 000000000 | |
| EP-1363613-A2 | Use of rhein for preparing a medicine for treating a high rate of il-1 | Withdrawn | 23-Jan-2001 | 000000000 | 0 |
| US-20020128317-A1 | Administering diacerein or rhein to treat inflammatory and autoimmune conditions characterized by an increased il-1 and or tnf alpha level | Abandoned | 23-Jan-2001 | 000000000 | 0 |
| AU-2001290033-A1 | Use of rhein for preparing a medicine for preventing articular cartilage damage | Abandoned | 15-Sep-2000 | A61K31/19 |
Laboratoires Negma Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Patrick Darses | Chief Executive Officer | ||
| Jean-Luc Barnoux | Managing Director & Director | ||
| Suzy Charbit | Managing Director & Director |
Laboratoires Negma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Laboratoires Negma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|